ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,583Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 229

$859K Total Retail Price of All Prescriptions

Rank: 8 out of 229

644 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 644 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 644 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 8,765 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 568 481 1 2
LEVOTHYROXINE SODIUM 545 435 2 1
SIMVASTATIN 532 477 3 3
HYDROCODONE-ACETAMINOPHEN 401 308 S3 4 7
AMLODIPINE BESYLATE 394 351 5 5
HYDROCHLOROTHIAZIDE 384 352 6 9
OMEPRAZOLE 350 270 7 4
ZOLPIDEM TARTRATE 322 263 8 20
METFORMIN HCL 316 269 9 6
TAMSULOSIN HCL 227 201 10 24
ATORVASTATIN CALCIUM 205 179 11 15
CRESTOR 197 167 12 30
LOSARTAN POTASSIUM 176 140 13 12
CITALOPRAM HBR 142 125 14 21
METOPROLOL TARTRATE 121 108 15 13
ENDOCET 118 42 S2 16 135
ALLOPURINOL 113 100 17 27
ATENOLOL 111 99 18 19
OXYCODONE HCL-ACETAMINOPHEN 105 67 S2 19 73
TRAMADOL HCL 105 92 19 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 93 19 28
LOVASTATIN 104 94 22 11
FLUTICASONE PROPIONATE 100 86 23 23
FUROSEMIDE 98 79 24 8
GABAPENTIN 97 73 25 10
TRIAMTERENE-HCTZ 93 93 26 51
PREDNISONE 91 71 27 35
GLIPIZIDE 84 59 28 36
LIPITOR 79 70 29 183
BENAZEPRIL HCL 78 78 30 86
SERTRALINE HCL 78 62 30 22
AMLODIPINE BESYLATE-BENAZEPRIL 76 76 32 120
SPIRONOLACTONE 75 68 33 56
FELODIPINE ER 74 71 34 61
ENALAPRIL MALEATE 68 49 35 54
CARVEDILOL 66 56 36 31
METOPROLOL SUCCINATE 64 58 37 16
CELEBREX 62 59 38 71
JANUVIA 61 32 39 59
LANTUS 55 35 40 40
FLUOXETINE HCL 51 40 41 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.